Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...

U.S. health authorities are considering how they might discourage or even ban vaccines that rely on a common ingredient to ...

Scientists have long hoped that GLP-1 medications could eventually treat all sorts of conditions involving impulse control ...

The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...

RFK Jr. is plowing ahead with sweeping changes to U.S. health care that have thrilled supporters, purged opponents, and ...

With limited food options, poor sleep, and pay-per-mile scales that incentivize sitting for long stretches, truckers are ...

A doctor who believes in miracles is one who doesn’t shut the door on the seemingly impossible too soon,” writes Marc Siegel, ...

Tatenda Makoni is a Zimbabwean-born medical student at the Medical College of Wisconsin whose work bridges global health and ...

WASHINGTON — Sen. Bill Cassidy (R-La.) is pitching Democrats on his compromise to make Affordable Care Act marketplace plans ...

A new analysis finds medicines often are not accessible countries where they were tested before approval by the FDA, raising ...

Over 74,000 people enrolled in experiments have been affected by the NIH's funding cuts, according to a new report.

Johnson & Johnson said it will purchase Halda Therapeutics, marking the first major buyout for a cancer drugmaker built ...